Higher throughput drug screening for rare respiratory diseases: readthrough therapy in primary ciliary dyskinesia
Open Access
- 1 April 2021
- journal article
- research article
- Published by European Respiratory Society (ERS) in European Respiratory Journal
- Vol. 58 (4) , 2000455
Abstract
Background: Development of therapeutic approaches for rare respiratory diseases is hampered by the lack of systems that allow medium-to-high-throughput screening of fully differentiated respiratory epithelium from affected patients. This is a particular problem for primary ciliary dyskinesia (PCD), a rare genetic disease caused by mutations in genes that adversely affect ciliary movement and consequently mucociliary transport. Primary cell culture of basal epithelial cells from nasal brush biopsies followed by ciliated differentiation at the air–liquid interface (ALI) has proven to be a useful tool in PCD diagnostics but the technique's broader utility, including in pre-clinical PCD research, has been restricted by the limited number of basal cells that can be expanded from such biopsies.Methods: We describe an immunofluorescence screening method, enabled by extensive expansion of basal cells from PCD patients and the directed differentiation of these cells into ciliated epithelium in miniaturised 96-well transwell format ALI cultures. As proof-of-principle, we performed a personalised investigation in a patient with a rare and severe form of PCD (reduced generation of motile cilia), in this case caused by a homozygous nonsense mutation in the MCIDAS gene.Results: Initial analyses of ciliary ultrastructure, beat pattern and beat frequency in the 96-well transwell format ALI cultures indicate that a range of different PCD defects can be retained in these cultures. The screening system in our proof-of-principal investigation allowed drugs that induce translational readthrough to be evaluated alone or in combination with nonsense-mediated decay inhibitors. We observed restoration of basal body formation but not the generation of cilia in the patient's nasal epithelial cells in vitro.Conclusion: Our study provides a platform for higher throughput analyses of airway epithelia that is applicable in a range of settings and suggests novel avenues for drug evaluation and development in PCD caused by nonsense mutations.Keywords
Funding Information
- Wellcome Trust (WT107963AIA, WT209199/Z/17/Z)
- Medical Research Council (MC_U12266B, MR/M02492X/1, MR/R015635/1)
- Great Ormond Street Hospital Charity (V4818)
- Action Medical Research (2336)
This publication has 56 references indexed in Scilit:
- CCDC65 Mutation Causes Primary Ciliary Dyskinesia with Normal Ultrastructure and Hyperkinetic CiliaPLOS ONE, 2013
- DYX1C1 is required for axonemal dynein assembly and ciliary motilityNature Genetics, 2013
- ciliaFA: a research tool for automated, high-throughput measurement of ciliary beat frequency using freely available softwareCilia, 2012
- Ciliary dysfunction and ultrastructural abnormalities are features of severe asthmaJournal of Allergy and Clinical Immunology, 2010
- Primary ciliary dyskinesia: a consensus statement on diagnostic and treatment approaches in childrenEuropean Respiratory Journal, 2009
- Centriole/basal body morphogenesis and migration during ciliogenesis in animal cellsJournal of Cell Science, 2007
- Rootletin Interacts with C-Nap1 and May Function as a Physical Linker between the Pair of Centrioles/Basal Bodies in CellsMolecular Biology of the Cell, 2006
- Ciliary beat pattern is associated with specific ultrastructural defects in primary ciliary dyskinesiaJournal of Allergy and Clinical Immunology, 2003
- Respiratory Syncytial Virus Infection of Human Airway Epithelial Cells Is Polarized, Specific to Ciliated Cells, and without Obvious CytopathologyJournal of Virology, 2002
- Analysis of ciliary beat pattern and beat frequency using digital high speed imaging: comparison with the photomultiplier and photodiode methodsThorax, 2000